Welcome to our dedicated page for Tilray Brands SEC filings (Ticker: TLRY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tilray Brands, Inc. filings document the public-company record for a Nasdaq-listed global cannabis, beverage and wellness business. Recent 8-K disclosures cover operating results, material agreements, equity offering arrangements, unregistered common stock issuances in debt-for-equity exchanges, and the registered status of TLRY common stock on The Nasdaq Global Select Market.
The filing record also documents Tilray’s completed acquisition of BrewDog business operations and assets, including brewery, online, retail, brewpub and brand intellectual-property assets. Governance and capital-structure filings address stockholder votes, board and charter proposals, auditor ratification, executive-compensation advisory voting, and the company’s reverse stock split.
Tilray Brands, Inc. files a prospectus supplement describing its capital structure, securities to be offered and material risks. The company says it is a global consumer products business operating in cannabis, beverage, wellness and entertainment with operations in Canada, the U.S., Europe, Australia, New Zealand and Latin America. Corporate actions disclosed include a name change to Tilray Brands, Inc., the Nov. 7, 2022 acquisition of Montauk Brewing, and the June 22, 2023 closing of the HEXO acquisition. As of Sept. 8, 2025, 1,118,291,159 shares of Common Stock were outstanding. 6,209,000 warrants remained outstanding and expire Sept. 17, 2025; exercise price was $0.3812 as of Sept. 5, 2025. The filing lists extensive forward-looking statements and numerous risk factors, and notes certain financial statement incorporations and auditor reliance.
Tilray Brands, Inc. (TLRY) – Form 4 filing dated 07/31/2025
Director Steven M. Cohen reported a single insider transaction on 07/29/2025. The company granted him 431,034 Restricted Stock Units (RSUs) at no cost (Transaction Code A). These RSUs represent the right to receive an equivalent number of TLRY common shares once vested. Vesting occurs one year after the grant date, contingent on continued board service, with accelerated vesting only upon death or disability; any voluntary resignation before that date results in forfeiture.
Following the grant, Cohen’s beneficial ownership is 431,034 derivative securities; no open-market purchases or sales of common stock were reported, and there were no changes in non-derivative holdings. The filing reflects standard director equity compensation and does not involve cash consideration or immediate dilution, as shares will be issued in the future upon vesting.
Tilray Brands (TLRY) director Johann Michael Herhalt filed a Form 4 covering routine equity-compensation activity.
- On 30-Jul-2025, 124,378 restricted stock units (RSUs) vested and converted to common shares (code M) at an imputed $0.61 per share.
- To cover withholding taxes, 65,921 shares were surrendered to the company (code F), resulting in a net issuance of 58,457 shares.
- Herhalt’s direct ownership rises to 174,009 common shares after the transactions.
- On 29-Jul-2025 he received a new grant of 431,034 RSUs that cliff-vest in one year, subject to continued service or earlier acceleration upon death/disability.
- All vested derivative holdings are now exhausted; the director holds 431,034 unvested RSUs.
The activity represents <1 % of Tilray’s outstanding share count and involves no cash outlay, implying negligible balance-sheet impact and de-minimis dilution.
Tilray Brands (TLRY) director David G. Hopkinson reported two equity-compensation transactions. On 29 Jul 2025 he received 431,034 new restricted stock units (RSUs); these cliff-vest one year from grant, with accelerated vesting only on death or disability and full forfeiture upon voluntary resignation before that date. On 30 Jul 2025 a prior RSU award vested, converting 124,378 units into common shares via an “M” code (derivative conversion) at an indicated price of $0.61 per share.
After the transactions Hopkinson directly holds 335,563 common shares and 431,034 unvested RSUs; no derivative balance remains from the vested grant. The Form 4 shows no open-market purchases or sales, suggesting these are routine director compensation events rather than directional trades.